|
|
|
40
|
51311
|
XALACOM 0.005% /0.5% EYE DR (PFI/STO) LATANOP
|
LATANOPROST|TIMOLOL
|
XALACOM
|
2.5ML
|
C
|
28.68
|
28.68
|
EYE DROP
|
0
|
BOTT
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
51311
|
XALACOM 0.005% /0.5% EYE DR (PFI/STO) LATANOP
|
LATANOPROST|TIMOLOL
|
XALACOM
|
2.5ML
|
C
|
37.89
|
37.89
|
EYE DROP
|
0
|
BOTT
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2022-07-27
|
2024-03-31
|
Price Change
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-07-26
|
|
|
|
41
|
51311
|
XALACOM 0.005%|0.5% EYE DR (PFI) LATANOPROST|TIMOLOL (C)
|
LATANOPROST|TIMOLOL
|
XALACOM
|
2.5ML
|
C
|
34.58
|
34.5771
|
BOTT
|
1
|
BOTT
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
51313
|
LOUTEN T 0.005% | 0.5% EYE DR (LPO/COL) LATANOP
|
LATANOPROST|TIMOLOL
|
LOUTEN T
|
2.5ML
|
A
|
13.05
|
13.05
|
EYE DROP
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
51313
|
LOUTEN T 0.005%|0.5% EYE DR (LPO) LATANO
|
LATANOPROST|TIMOLOL
|
LOUTEN T
|
2.5ML
|
A
|
14.35
|
14.3528
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
51313
|
LOUTEN T 0.005%|0.5% EYE DR (LPO) LATANOPROST|TIMOLOL
|
LATANOPROST|TIMOLOL
|
LOUTEN T
|
2.5ML
|
C
|
17.67
|
17.67
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
AVENTA BARBADOS
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
51316
|
XALACOM 0.005% /0.5% EYE DR (PFI/SBI) LATANOP
|
LATANOPROST|TIMOLOL
|
XALACOM
|
2.5ML
|
C
|
37.90
|
37.90
|
EYE DROP
|
0
|
BOTT
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
Price Change
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-05-05
|
|
|
|
41
|
51316
|
XALACOM 0.005%|0.5% EYE DR (PFI) LATANOPROST|TIMOLOL (C)
|
LATANOPROST|TIMOLOL
|
XALACOM
|
2.5ML
|
C
|
34.58
|
34.5771
|
BOTT
|
1
|
BOTT
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
5131BL
|
LATANOPROST|TIMOLOL EYE DR (MTP)
|
LATANOPROST|TIMOLOL
|
LATANOPROST|TIMOLOL
|
2.5ML
|
A
|
8.86
|
8.86
|
BOTT
|
1
|
BOTT
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
5131Q
|
XALACOM 0.005%|0.5% EYE DR (PFI) LATANOPROST|TIMOLOL
|
LATANOPROST|TIMOLOL
|
XALACOM
|
2.5ML
|
C
|
34.58
|
34.58
|
BOTT
|
1
|
BOTT
|
PFI
|
PFIZER CORPORATION
|
COL
|
AVENTA BARBADOS
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
A5311
|
XALATAN 0.005% EYE DR (PFI/STO) LATANOPROST
|
LATANOPROST
|
XALATAN
|
2.5ML
|
A
|
11.66
|
11.66
|
EYE DROP
|
1
|
BOTT
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
B
|
524028
|
EENT PROSTAGLANDIN ANALOGS
|
2022-04-01
|
2024-03-31
|
Price Change
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-05-03
|
|
|
|
40
|
A531AH
|
LOUTEN EMULSION 0.005% EYE DR (LPO/COL) LATAN
|
LATANOPROST
|
LOUTEN EMULSION
|
2.5ML
|
A
|
9.08
|
9.08
|
EYE DROP
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
B
|
524028
|
EENT PROSTAGLANDIN ANALOGS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-02-18
|
|
|
|
41
|
A531AH
|
LOUTEN EMULSION 0.005% EYE DR (LPO) LATA
|
LATANOPROST
|
LOUTEN EMULSION
|
2.5ML
|
A
|
9.08
|
9.0792
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
B
|
524028
|
EENT PROSTAGLANDIN ANALOGS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT PROSTAGLANDIN ANALOGS
|
|
|
|
|
42
|
A531AH
|
LOUTEN EMULSION 0.005% EYE DR (LPO) LATA
|
LATANOPROST
|
LOUTEN EMULSION
|
2.5ML
|
C
|
16.31
|
16.31
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
AVENTA BARBADOS
|
B
|
524028
|
EENT PROSTAGLANDIN ANALOGS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
EENT PROSTAGLANDIN ANALOGS
|
|
|
|
|
41
|
A531BF
|
XALATAN 0.005% EYE DR (PFI) LATANOPROST
|
LATANOPROST
|
XALATAN
|
2.5ML
|
A
|
8.86
|
8.8617
|
BOTT
|
2
|
BOTT
|
PFI
|
PFIZER CORPORATION
|
COL
|
COLLINS LIMITED
|
B
|
524028
|
EENT PROSTAGLANDIN ANALOGS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT PROSTAGLANDIN ANALOGS
|
2025-04-01
|
|
|
|
42
|
A531BF
|
XALATAN 0.005% EYE DR (PFI) LATANOPROST
|
LATANOPROST
|
XALATAN
|
2.5ML
|
A
|
8.51
|
8.51
|
BOTT
|
1
|
BOTT
|
PFI
|
PFIZER CORPORATION
|
COL
|
AVENTA BARBADOS
|
B
|
524028
|
EENT PROSTAGLANDIN ANALOGS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
EENT PROSTAGLANDIN ANALOGS
|
|
|
|
|
40
|
A531H
|
XALATAN 0.005% EYE DR (PFI/SBI) LATANOPROST
|
LATANOPROST
|
XALATAN
|
2.5ML
|
A
|
11.66
|
11.66
|
EYE DROP
|
1
|
BOTT
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
524028
|
EENT PROSTAGLANDIN ANALOGS
|
2022-04-01
|
2024-03-31
|
Price Change
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-05-03
|
|
|
|
41
|
A531H
|
XALATAN 0.005% EYE DR (PFI) LATANOPROST
|
LATANOPROST
|
XALATAN
|
2.5ML
|
A
|
8.86
|
8.8617
|
BOTT
|
1
|
BOTT
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
524028
|
EENT PROSTAGLANDIN ANALOGS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT PROSTAGLANDIN ANALOGS
|
|